Tizanidine Tablet
Product Images NDC 70518-3658

8 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 70518-3658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Tizanidine hydrochloride, depicting the molecular arrangement including nitrogen and chlorine atoms as part of its chemical composition.*
FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A pharmacokinetic graph showing plasma Tizanidine concentration (ng/mL) over time (hours) after dosing. The graph compares four groups: 2 x 4 mg Tizanidine tablets with food, without food, and 2 x 4 mg Tizanidine capsules with and without food. Concentrations peak within the first few hours and decrease to near zero by 12-16 hours post dosing.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A line graph showing improvement in Ashworth score over hours post-dose comparing 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The x-axis represents hours post-dose (0 to 6), and the y-axis represents improvement in Ashworth score from 0 to -5. The 16 mg dose shows the greatest improvement at around 2 hours, followed by 8 mg and then placebo.*
FDA Label Image

Fig3 (Fig3)

Fig3 (Fig3)
A line chart comparing improvement in Ashworth Score between tizanidine (mean dose 28.8 mg) and placebo across three time points: end of titration (week 3), end of maintenance (week 7), and endpoint (last observation carried forward). The chart shows mean scores with error bars for each group at each time point.*
FDA Label Image

Mm1 (Tizanidine 4mg 70518 3658 00)

Mm1 (Tizanidine 4mg 70518 3658 00)
Tizanidine Tablet 4 mg label for a bottle containing 30 tablets. The label states it is repackaged by RemedyRepack Inc., Indiana, PA. It includes storage instructions, a warning that tablets are not interchangeable with capsules, and manufacturer details for Northstar Rx LLC. The NDC is 70518-3658-00.*
FDA Label Image

Mm2 (Tizanidine 4mg 70518 3658 01)

Mm2 (Tizanidine 4mg 70518 3658 01)
Label for Tizanidine Tablets 4 mg, oral dosage form, repackaged by RemedyRepack Inc. The label indicates a quantity of 90 tablets, white oval shape with imprint R 180. It includes storage instructions and a warning that Tizanidine tablets are not interchangeable with capsules. The label also shows the NDC number 70518-3658-01 and manufacturer Northstar Rx LLC.*
FDA Label Image

Mm3 (Tizanidine 4mg 70518 3658 02)

Mm3 (Tizanidine 4mg 70518 3658 02)
Tizanidine Tablet 4 mg label showing dosage form as oral tablets with a quantity of 60 tablets. The label includes the NDC number 70518-3658-02 and indicates the product is RX only. It is repackaged by RemedyRepack Inc., located in Indiana, PA. Storage instructions and a warning that Tizanidine Tablets are not interchangeable with capsules are included.*
FDA Label Image

Mm4 (Tizanidine 4mg 70518 3658 03)

Mm4 (Tizanidine 4mg 70518 3658 03)
Tizanidine 4 mg tablet label showing quantity of 15 tablets. The label indicates the drug is repackaged by RemedyRepack Inc. It includes storage instructions and a warning that tablets are not interchangeable with capsules. The label features the NDC 70518-3658-03 and is marked RX Only. Manufacturer details and a QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.